Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $52.50 USD
Change Today +0.165 / 0.32%
Volume 3.2K
NVZMY On Other Exchanges
Symbol
Exchange
NVZMY is not on other exchanges.
As of 2:06 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

novozymes a/s-unspons adr (NVZMY) Snapshot

Open
$52.70
Previous Close
$52.33
Day High
$52.78
Day Low
$52.46
52 Week High
07/31/15 - $52.83
52 Week Low
10/16/14 - $38.30
Market Cap
16.4B
Average Volume 10 Days
45.9K
EPS TTM
--
Shares Outstanding
259.3M
EX-Date
03/3/15
P/E TM
--
Dividend
$0.45
Dividend Yield
0.86%
Current Stock Chart for NOVOZYMES A/S-UNSPONS ADR (NVZMY)

Related News

No related news articles were found.

novozymes a/s-unspons adr (NVZMY) Related Businessweek News

No Related Businessweek News Found

novozymes a/s-unspons adr (NVZMY) Details

Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. The company offers solutions for the agriculture industry, including enzymes to enhance digestibility and nutritional value of animal feed; microbial solutions to maintain water quality, limit risks of disease, and enhance yields in aquaculture; and microbial-based biofertility, biocontrol, and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; recombinant products and technologies to the medical device and drug delivery market; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and microbial solutions for biological wastewater treatment. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

6,486 Employees
Last Reported Date: 04/23/15
Founded in 1925

novozymes a/s-unspons adr (NVZMY) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: kr9.7M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: kr5.9M
Executive Vice President of Business Operatio...
Total Annual Compensation: kr5.4M
Executive Vice President of Research & Develo...
Total Annual Compensation: kr6.0M
Executive Vice President of Supply Operations
Total Annual Compensation: kr5.9M
Compensation as of Fiscal Year 2014.

novozymes a/s-unspons adr (NVZMY) Key Developments

Novozymes A/S Presents at Navigating the Nordics Seminar, Jun-09-2015

Novozymes A/S Presents at Navigating the Nordics Seminar, Jun-09-2015 . Venue: Stockholm, Sweden.

Novozymes to Establish New Research and Development Centre

Novozymes is to establish a new research and development Centre in the country's Lyngby-Taarbaek municipality. The first phase of work on the 140,000 square metre (sqm) site will be to create a 30,000sqm development with room for 800 employees. The site is expected to fulfil the company’s research expansion requirements in the country until 2023, with scope to develop the site into a centre for 2,000-2,500 employees. The cost of the project was not disclosed, but has been factored into the company's existing capital expenditure plans, which are expected to average 8% of turnover in 2015-2020. The new campus is expected to be inaugurated in 2018.

Adisseo and Novozymes Announce Partnership to Develop and Market a Probiotic for Poultry

Adisseo and Novozymes, announced a partnership to develop and market a probiotic for poultry. Novozymes will be responsible for in-vitro screening, development and production, while Adisseo will manage in-vivo testing, marketing and sales. The partners expect to launch the product within the next 12 months.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVZMY:US $52.50 USD +0.165

NVZMY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chr Hansen Holding A/S kr375.00 DKK 0.00
Ebro Foods SA €18.81 EUR +0.63
EMS-Chemie Holding AG SFr.463.50 CHF -8.00
Kerry Group PLC €70.45 EUR +1.30
Sensient Technologies Corp $68.05 USD -0.34
View Industry Companies
 

Industry Analysis

NVZMY

Industry Average

Valuation NVZMY Industry Range
Price/Earnings 44.9x
Price/Sales 8.6x
Price/Book 9.9x
Price/Cash Flow 37.1x
TEV/Sales 7.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-UNSPONS ADR, please visit www.novozymes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.